Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Erlangen-Nürnberg Medical School
About this trial
In this study, the condition of the kidney transplant in adults is to be assessed non-invasively using Multispectral Optoacoustic Tomography and Ultrasound Localization Microscopy (ULM). ULM imaging can be performed in a 2-dimensional and a 3-dimensional way (2D and 3D ULM). Therefore, "ULM" in the following texts and measures will refer to 2D and 3D ULM.
New, non-invasive markers that allow conclusions to be drawn about the condition of the transplant should reduce the need for invasive diagnostic procedures in the future.
Eligibility criteria
Qualifiers
kidney transplant
indication for biopsy set in clinical routine
minimum 18 years of age
written consent
Disqualifiers
allergy against contrast agents/ SonoVue
tatoos in examined areas
contraindication against SonoVue
pregnant women
Trial design
Treatments tested in this trial
- ULM and MSOT
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov